Differential drug resistance acquisition to doxorubicin and paclitaxel in breast cancer cells

被引：0
|
作者：
Feifei Xu
Fengliang Wang
Ting Yang
Yuan Sheng
Ting Zhong
Yun Chen
机构：
[1] Nanjing Medical University,School of Pharmacy
[2] Nanjing Maternity and Child Health Care Hospital,undefined
来源：
Cancer Cell International | / 14卷
关键词：
Multi-drug Resistance Acquisition (MDR); P-glycoprotein (P-gp); Drug-specific; Doxorubicin (DOX); Paclitaxel (PTX);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Differential drug resistance acquisition to doxorubicin and paclitaxel in breast cancer cells
    Xu, Feifei
    Wang, Fengliang
    Yang, Ting
    Sheng, Yuan
    Zhong, Ting
    Chen, Yun
    CANCER CELL INTERNATIONAL, 2014, 14
  • [2] Reversal of epigenetic aberrations associated with the acquisition of doxorubicin resistance restores drug sensitivity in breast cancer cells
    Ponnusamy, Logeswari
    Mahalingaiah, Prathap Kumar S.
    Chang, Yu-Wei
    Singh, Kamaleshwar P.
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 123 : 56 - 69
  • [3] Influence of estrogen receptor status on acquisition of doxorubicin resistance in breast cancer cells
    Ponnusamy, Logeswari
    Kumar, Prathap
    Mahalingaiah, Salakatte
    Singh, Kamaleshwar P.
    CANCER RESEARCH, 2016, 76
  • [4] Role of drug selection dose in the acquisition of progressive resistance to doxorubicin, epirubicin, paclitaxel or docetaxel in MCF-7 breast tumour cells
    Veitch, Zachary
    Hembruff, Stacey L.
    Laberge, Monique L.
    Villeneuve, David J.
    Cecchetto, Melanie
    Shuart, Melissa
    Parissenti, Amadeo M.
    CANCER RESEARCH, 2006, 66 (08)
  • [5] DIFFERENTIAL EXPRESSION OF DRUG METABOLISM ENZYMES IN DOXORUBICIN RESISTANT BREAST CANCER CELLS
    Barata, Isabel
    Gomes, Bruno C.
    Rodrigues, Antonio S.
    Rueff, Jose
    Kranendonk, Michel
    Esteves, Francisco
    MEDICINE, 2023, 102 (13)
  • [6] Hyperactivated m-calpain affects acquisition of doxorubicin resistance in breast cancer cells
    Jeon, Kyung-Hwa
    Yu, Han Vit
    Kwon, Youngjoo
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2018, 1862 (05): : 1126 - 1133
  • [7] Growth of human breast cancer cells at acidic pH enhances their resistance to paclitaxel and doxorubicin.
    Cheng, H
    Cobos, E
    Jackson, M
    Martinez, GM
    Martinez-Zaguilan, R
    BLOOD, 2000, 96 (11) : 100A - 100A
  • [8] Paclitaxel in breast cancer - drug resistance and strategies to counteract it
    Zajdel, Alicja
    Wolny, Daniel
    Kalucka-Janik, Magdalena
    Wilczok, Adam
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2019, 73 : 508 - 515
  • [9] The role of microRNAs on doxorubicin drug resistance in breast cancer
    Jamialahmadi, Khadijeh
    Zahedipour, Fatemeh
    Karimi, Gholamreza
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2021, 73 (08) : 997 - 1006
  • [10] Treatment schedules influence acquisition of Doxorubicin resistance through epigenetic mechanism in breast cancer cells
    Ponnusamy, Logeswari
    Mahalingaiah, Prathap Kumar S.
    Singh, Kamaleshwar P.
    CANCER RESEARCH, 2017, 77
12345